Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27903516)

Published in Am J Physiol Regul Integr Comp Physiol on November 30, 2016

Authors

Frank T Spradley1

Author Affiliations

1: Department of Surgery, Department of Physiology and Biophysics, Cardiovascular-Renal Research Center, Women's Health Research Center, The University of Mississippi Medical Center, Jackson, Mississippi fspradley@umc.edu.

Articles cited by this

Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol (2013) 6.24

Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol (2015) 6.11

Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care (2007) 3.27

Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. N Engl J Med (2016) 2.73

Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta (2008) 2.67

The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care (2012) 2.61

Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation (2009) 2.54

Nitric oxide and pregnancy. Am J Physiol (1997) 2.38

Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ (2010) 2.37

IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta (2014) 1.87

Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth. Proc Natl Acad Sci U S A (2015) 1.81

Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol (1989) 1.71

Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension (2013) 1.71

Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology (2011) 1.66

A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv (2011) 1.58

Maternal prepregnancy body mass index and gestational weight gain on pregnancy outcomes. PLoS One (2013) 1.48

Pre-pregnancy body mass index and weight gain during pregnancy: relations with gestational diabetes and hypertension, and birth outcomes. Matern Child Health J (2012) 1.27

Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension (2010) 1.11

Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation (2013) 1.09

Placental amino acid transport and placental leptin resistance in pregnancies complicated by maternal obesity. Placenta (2010) 1.07

Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol (2011) 1.06

Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension (2001) 1.02

Physiological changes in early pregnancy. J Obstet Gynaecol Br Commonw (1968) 1.01

Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol (2012) 0.98

Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia? Hypertension (2012) 0.96

Feto-placental adaptations to maternal obesity in the baboon. Placenta (2009) 0.96

A systematic review of metabolite profiling in gestational diabetes mellitus. Diabetologia (2014) 0.96

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia. Hypertension (2004) 0.95

Maternal serum adiponectin multimers in gestational diabetes. J Perinat Med (2009) 0.94

Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol (2007) 0.93

Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br J Pharmacol (1996) 0.92

Maternal serum adiponectin multimers in preeclampsia. J Perinat Med (2009) 0.92

Obesity during pregnancy disrupts placental morphology, cell proliferation, and inflammation in a sex-specific manner across gestation in the mouse. Biol Reprod (2014) 0.92

Monocytes and macrophages in pregnancy and pre-eclampsia. Front Immunol (2014) 0.91

Toll-like receptor 4 on islet β cells senses expression changes in high-mobility group box 1 and contributes to the initiation of type 1 diabetes. Exp Mol Med (2012) 0.90

Insulin requires normal expression and signaling of insulin receptor A to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium. FASEB J (2014) 0.89

Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother-offspring pairs: findings from a prospective pregnancy cohort. Diabetologia (2014) 0.88

Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta. Int J Clin Exp Pathol (2013) 0.88

Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells. Int J Obes (Lond) (2014) 0.88

Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation. Ultrasound Obstet Gynecol (2008) 0.86

Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol (2015) 0.86

The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab (2015) 0.85

Neutrophil infiltration and systemic vascular inflammation in obese women. Reprod Sci (2009) 0.84

Adverse adipose phenotype and hyperinsulinemia in gravid mice deficient in placental growth factor. Endocrinology (2008) 0.84

Chorionic plate arterial function is altered in maternal obesity. Placenta (2013) 0.84

Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol (2015) 0.84

Association between maternal serum high mobility group box 1 levels and pregnancy complicated by gestational diabetes mellitus. Nutr Metab Cardiovasc Dis (2016) 0.83

Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers. BMJ Open Diabetes Res Care (2014) 0.83

Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with pre-existing maternal obesity and gestational diabetes. Metabolism (2014) 0.83

Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas. Placenta (2006) 0.83

Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats. J Vasc Res (2011) 0.83

Maternal Body Weight and Gestational Diabetes Differentially Influence Placental and Pregnancy Outcomes. J Clin Endocrinol Metab (2015) 0.83

Hyperglycemia impairs cytotrophoblast function via stress signaling. Am J Obstet Gynecol (2014) 0.83

Treatment with constitutive androstane receptor ligand during pregnancy prevents insulin resistance in offspring from high-fat diet-induced obese pregnant mice. Am J Physiol Endocrinol Metab (2012) 0.82

Is heparin a placental anticoagulant in high-risk pregnancies? Blood (2011) 0.82

Placental pathologic changes in gestational diabetes mellitus. Neuro Endocrinol Lett (2015) 0.82

Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care (2007) 0.81

Abnormal spiral arteries modification in stillbirths: the role of maternal prepregnancy body mass index. J Matern Fetal Neonatal Med (2012) 0.81

NO from smooth muscle cells decreases NOS expression in endothelial cells: role of TNF-alpha. Am J Physiol (1999) 0.81

Maternal obesity and sex-specific differences in placental pathology. Placenta (2015) 0.81

The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies. Am J Obstet Gynecol (2014) 0.80

Streptozotocin-induced diabetic pregnant rats exhibit signs and symptoms mimicking preeclampsia. Metabolism (2000) 0.80

Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus. Diabetes Care (2016) 0.80

Prevalence of gestational diabetes and risk of complications before and after initiation of a general systematic two-step screening strategy in Germany (2012-2014). Diabetes Res Clin Pract (2016) 0.79

Concentration of cord serum placenta growth factor in normal and diabetic pregnancies. BJOG (2005) 0.79

The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy (2013) 0.79

Risks of gestational diabetes and preeclampsia over the last decade in a cohort of Alberta women. J Obstet Gynaecol Can (2013) 0.78

Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant women. J Am Soc Hypertens (2013) 0.78

Impaired proliferation of pancreatic beta cells, by reduced placental growth factor in pre-eclampsia, as a cause for gestational diabetes mellitus. Cell Prolif (2015) 0.78

Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: A systematic review. J Diabetes Complications (2016) 0.78

First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors. Prenat Diagn (2014) 0.78

Hypoxic trophoblast HMGB1 induces endothelial cell hyperpermeability via the TRL-4/caveolin-1 pathway. J Immunol (2014) 0.77

Placental growth factor influences maternal cardiovascular adaptation to pregnancy in mice. Biol Reprod (2014) 0.77

Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia. Reprod Sci (2014) 0.77

Impact of obesity on endometrial blood flow in women without polycystic ovarian syndrome during intracytoplasmic sperm injection. Reprod Biol Endocrinol (2013) 0.77

Human supraphysiological gestational weight gain and fetoplacental vascular dysfunction. Int J Obes (Lond) (2015) 0.77

Severe superimposed preeclampsia with obesity, diabetes and a mild imbalance of angiogenic factors. Acta Med Okayama (2012) 0.77

Circulatory and renal consequences of pregnancy in diabetic NOD mice. Placenta (2011) 0.77

Obesity and Placental Function. Semin Reprod Med (2016) 0.77

Pre-pregnancy maternal obesity and the risk of preterm preeclampsia in the American primigravida. Obesity (Silver Spring) (2016) 0.77

Insulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium. Purinergic Signal (2015) 0.76

HMGB1-RAGE signaling pathway in severe preeclampsia. Placenta (2015) 0.76

AGEs and HMGB1 Increase Inflammatory Cytokine Production from Human Placental Cells, Resulting in an Enhancement of Monocyte Migration. Am J Reprod Immunol (2016) 0.76

Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study. J Thromb Haemost (2016) 0.76

Placental morphology in pregnancies associated with pregravid obesity. J Matern Fetal Neonatal Med (2015) 0.76

Degree of obesity at delivery and risk of preeclampsia with severe features. Am J Obstet Gynecol (2015) 0.76

Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta (2015) 0.76

Increased Risk of Intracranial Hemorrhage in Patients With Pregnancy-Induced Hypertension: A Nationwide Population-Based Retrospective Cohort Study. Medicine (Baltimore) (2016) 0.76

Obstetric Outcome in Early and Late Onset Gestational Diabetes Mellitus. Mymensingh Med J (2015) 0.76

Maternal obesity impairs specific regulatory pathways in human myometrial arteries. Biol Reprod (2014) 0.76

Overweight and obesity: a remaining problem in women treated for severe gestational diabetes. Diabet Med (2016) 0.76

Fasting glycemia at the first prenatal visit and pregnancy outcomes in Russian women. Minerva Endocrinol (2016) 0.76

Dietary fructose in pregnancy induces hyperglycemia, hypertension, and pathologic kidney and liver changes in a rodent model. Pregnancy Hypertens (2015) 0.76

Chronic hyperleptinemia results in the development of hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol (2015) 0.76

Establishment of ApoE-knockout mouse model of preeclampsia and relevant mechanisms. Exp Ther Med (2016) 0.75

Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes. Diabetologia (2016) 0.75

Dimethylesculetin ameliorates maternal glucose intolerance and fetal overgrowth in high-fat diet-fed pregnant mice via constitutive androstane receptor. Mol Cell Biochem (2016) 0.75

Increased expression of high mobility group box 1 (HMGB1) in the cytoplasm of placental syncytiotrophoblast from preeclamptic placentae. Cytokine (2016) 0.75